Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients.

Vidarsdottir, Linda; Olafsdottir, Elinborg J; Barkardottir, Rosa B; Bjarnadottir, Olöf; Jonasson, Jon G; Sigurdsson, Stefan; Tryggvadottir, Laufey.

Afiliação

Vidarsdottir L; Faculty of Medicine, University of Iceland, Sturlugata 8, Reykjavik, Iceland.
Olafsdottir EJ; BioMedical Center, University of Iceland, Sturlugata 8, Reykjavik, Iceland.
Barkardottir RB; Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.
Bjarnadottir O; BioMedical Center, University of Iceland, Sturlugata 8, Reykjavik, Iceland.
Jonasson JG; Department of Pathology, Landspitali-University Hospital, Reykjavik, Iceland.
Sigurdsson S; Department of Oncology, Landspitali-University Hospital, Reykjavik, Iceland.
Tryggvadottir L; Faculty of Medicine, University of Iceland, Sturlugata 8, Reykjavik, Iceland.

NPJ Breast Cancer ; 9(1): 95, 2023 Nov 30.

Article em En | MEDLINE | ID: mdl-38036573

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article